drugset / Trial / NCT06137300
Safety and Efficacy of Urinary Kallidinogenase for Large Artery Atherosclerosis Acute Ischemic Stroke
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of urinary kallidinogenase treatment in patients with large artery atherosclerotic acute ischemic stroke.
Timeline
- Start
- 2024-03-15
- Primary completion
- 2026-06-30
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Urinary Kallidinogenase | Unknown | 0.15 unknown | — |